
Oocyte Collection System Market Report 2026
Global Outlook – By Product Type (Aspiration Needles, Single Lumen Needles, Double Lumen Needles, Vacuum Aspiration Pumps, Suction Tubing Sets, Oocyte Collection Tubes, Collection Chambers, Follicle Flushing Systems), By Technological Modalities (Automated Aspiration Systems, Fully Automated Systems, Semi Automated Systems, Manual Systems, Handheld Variants), By Usability (Disposable Systems, Reusable Systems), By Distribution Channel (Direct Sales, Medical Device Distributors, Online Sales Channels, Specialty Medical Suppliers, Other Distribution Channels), By End User (Fertility Clinics And Assisted Reproductive Technology Centers, Hospitals With Reproductive Medicine Departments, Cryobanks And Egg Banking Facilities, Research And Academic Institutes) – Market Size, Trends, Strategies, and Forecast to 2030
Oocyte Collection System Market Overview
• Oocyte Collection System market size has reached to $6.17 billion in 2025 • Expected to grow to $12.91 billion in 2030 at a compound annual growth rate (CAGR) of 15.8% • Growth Driver: Increasing Global Infertility Rates Driving The Market Growth Due To Delayed Parenthood, Lifestyle Changes, And Reproductive Health Disorders • Market Trend: Manufacturers Introduce Advanced Needle Designs To Improve Ultrasound Visibility And Procedural Control • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Oocyte Collection System Market?
An oocyte collection system is a medical device system used in assisted reproductive procedures to retrieve oocytes from ovarian follicles under controlled clinical conditions. It is designed to enable precise follicular access, controlled aspiration, and secure transfer of retrieved biological material while maintaining sterility, pressure stability, and temperature-controlled handling conditions. The system supports minimally invasive reproductive procedures by ensuring consistent fluid dynamics, sample integrity, and procedural safety during oocyte retrieval processes. The main product types of oocyte collection systems include aspiration needles, single lumen needles, double lumen needles, vacuum aspiration pumps, suction tubing sets, oocyte collection tubes, collection chambers, and follicle flushing systems. Aspiration needles refer to specialized sterile needles used during oocyte retrieval procedures to aspirate follicular fluid and collect oocytes from ovarian follicles under ultrasound guidance. These systems utilize technological modalities including automated aspiration systems, fully automated systems, semi automated systems, manual systems, and handheld variants and are available as disposable systems and reusable systems. They are distributed through direct sales, medical device distributors, online sales channels, specialty medical suppliers, and others and are utilized by end users including fertility clinics and assisted reproductive technology centers, hospitals with reproductive medicine departments, cryobanks and egg banking facilities, and research and academic institutes.
What Is The Oocyte Collection System Market Size and Share 2026?
The oocyte collection system market size has grown rapidly in recent years. It will grow from $6.17 billion in 2025 to $7.17 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to growing demand for assisted reproductive technologies, increasing infertility treatment procedures, rising adoption of minimally invasive fertility procedures, expanding fertility clinic infrastructure, higher awareness of reproductive health services.What Is The Oocyte Collection System Market Growth Forecast?
The oocyte collection system market size is expected to see rapid growth in the next few years. It will grow to $12.91 billion in 2030 at a compound annual growth rate (CAGR) of 15.8%. The growth in the forecast period can be attributed to increasing demand for advanced oocyte retrieval systems, rising investment in fertility treatment infrastructure, growing adoption of automated aspiration technologies, expanding access to assisted reproductive services, higher focus on improving oocyte retrieval efficiency. Major trends in the forecast period include growing adoption of minimally invasive oocyte retrieval procedures, increasing demand for precision follicular aspiration systems, rising focus on sterile single use collection devices, expansion of temperature controlled sample handling solutions, higher preference for integrated oocyte retrieval workflows.
Global Oocyte Collection System Market Segmentation
1) By Product Type: Aspiration Needles, Single Lumen Needles, Double Lumen Needles, Vacuum Aspiration Pumps, Suction Tubing Sets, Oocyte Collection Tubes, Collection Chambers, Follicle Flushing Systems 2) By Technological Modalities: Automated Aspiration Systems, Fully Automated Systems, Semi Automated Systems, Manual Systems, Handheld Variants 3) By Usability: Disposable Systems, Reusable Systems 4) By Distribution Channel: Direct Sales, Medical Device Distributors, Online Sales Channels, Specialty Medical Suppliers, Other Distribution Channels 5) By End User: Fertility Clinics And Assisted Reproductive Technology Centers, Hospitals With Reproductive Medicine Departments, Cryobanks And Egg Banking Facilities, Research And Academic Institutes Subsegments: 1) By Aspiration Needles: Follicular Aspiration Needles, Echogenic Aspiration Needles, Ultrasound Guided Aspiration Needles, Reusable Aspiration Needles 2) By Single Lumen Needles: Standard Single Lumen Retrieval Needles, Echogenic Single Lumen Needles, Fixed Curvature Single Lumen Needles, Reinforced Shaft Single Lumen Needles 3) By Double Lumen Needles: Follicle Aspiration And Flushing Double Lumen Needles, Coaxial Double Lumen Needles, Offset Tip Double Lumen Needles, Echogenic Double Lumen Needles 4) By Vacuum Aspiration Pumps: Electronic Vacuum Aspiration Pumps, Manual Vacuum Aspiration Pumps, Programmable Vacuum Aspiration Pumps, Portable Vacuum Aspiration Pumps 5) By Suction Tubing Sets: Standard Suction Tubing Sets, Sterile Disposable Suction Tubing Sets, Reinforced Suction Tubing Sets, Anti Kink Suction Tubing Sets 6) By Oocyte Collection Tubes: Sterile Collection Tubes, Temperature Controlled Collection Tubes, Graduated Collection Tubes, Micro Volume Collection Tubes 7) By Collection Chambers: Single Chamber Collection Units, Multi Chamber Collection Units, Temperature Stabilized Collection Chambers, Integrated Filtration Collection Chambers 8) By Follicle Flushing Systems: Manual Flushing Systems, Automated Flushing Systems, Closed Loop Flushing Systems, Dual Channel Flushing SystemsWhat Is The Driver Of The Oocyte Collection System Market?
The increasing global infertility rates are expected to propel the growth of the oocyte collection system market going forward. Infertility refers to the inability to conceive after a prolonged period of regular, unprotected intercourse, and its prevalence is rising across both developed and developing regions. Infertility rates are rising due to delayed parenthood as people choose to have children at older ages, natural fertility declines with age especially in women due to a reduction in both the quantity and quality of eggs making conception more difficult. Oocyte collection system is used to enable the safe and efficient retrieval of mature eggs from a woman’s ovaries during assisted reproductive procedures such as IVF, thereby increasing the chances of successful fertilization and conception in individuals affected by declining fertility rates. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people globally, face infertility, highlighting the pressing need to improve access to affordable, high-quality fertility care for those affected. Therefore, the increasing global infertility rates are driving the growth of the oocyte collection system industry.Key Players In The Global Oocyte Collection System Market
Major companies operating in the oocyte collection system market are CooperSurgical Inc., Vitrolife AB, Nexpring Health, Genea Biomedx, Esco Medical ApS, Rocket Medical plc, BIRR BioSciences B.V., SparMED ApS, Laboratoire CCD S.A.S., Labotect GmbH, MedGyn Products Inc., Vitromed GmbH, RI.MOS S.r.l., Gynotec B.V.
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.

This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Global Oocyte Collection System Market Trends and Insights
Major companies operating in the oocyte collection system market are focusing on aspiration needle design innovation, such as enhanced echogenic surface technology, to help clinicians retrieve oocytes with greater precision and reduced procedural risk. Enhanced echogenic surface technology refers to a needle surface treatment that improves how clearly the needle tip appears under ultrasound guidance, helping the clinician track its position throughout the retrieval procedure. For instance, in November 2025, Rocket Medical plc, a UK-based medical device company, introduced the Embryon SX single lumen aspiration needle to enhance oocyte retrieval accuracy and ultrasound-guided visualization during IVF procedures, while improving procedural control and minimizing patient trauma. The needle features a spiral echo bevel design for high-resolution ultrasound definition, a shaped finger grip with a bevel marker to aid control during the procedure, and an Oxford tubing set with a clear silicone bung for secure connection to the aspiration line.What Are Latest Mergers And Acquisitions In The Oocyte Collection System Market?
In October 2023, Hamilton Thorne Ltd., a Canada-based precision instruments and assisted reproductive technology (ART) company, acquired Gynetics Medical Products N.V. for an undisclosed amount. With this acquisition, Hamilton Thorne Ltd. aims to strengthen and expand its consumables and clinical product portfolio within the global IVF and assisted reproductive technology market by adding high-quality, recurring-revenue IVF consumables, enhancing its presence in the European ART sector, and leveraging synergies between its existing distribution channels and Gynetics’ established embryo transfer and ovum pick-up product lines to drive broader international commercialization and long-term revenue growth in fertility care solutions. Gynetics Medical Products N.V. is a Belgium-based medical device company that specializes in designing and manufacturing oocyte collection system.
Regional Outlook
North America was the largest region in the oocyte collection system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Oocyte Collection System Market?
The oocyte collection system market consists of sales of integrated oocyte retrieval systems, closed fluid handling systems, aspiration control units, collection and transfer assemblies, sterile collection kits, and associated supporting device configurations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.

This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
What Key Data and Analysis Are Included in the Oocyte Collection System Market Report 2026?
The oocyte collection system market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oocyte collection system industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Oocyte Collection System Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $7.17 billion |
| Revenue Forecast In 2030 | $12.91 billion |
| Growth Rate | CAGR of 15.8% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Technological Modalities, Usability, Distribution Channel, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | CooperSurgical Inc., Vitrolife AB, Nexpring Health, Genea Biomedx, Esco Medical ApS, Rocket Medical plc, BIRR BioSciences B.V., SparMED ApS, Laboratoire CCD S.A.S., Labotect GmbH, MedGyn Products Inc., Vitromed GmbH, RI.MOS S.r.l., Gynotec B.V. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
